Greenhaven Road Investment Management L.P. 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-14 4:44 pm Purchase | 2024-12-31 | 13G | Lifecore Biomedical, Inc. LFCR | Greenhaven Road Investment Management L.P. | 3,616,146 9.800% | 1,249,190![]() (+52.78%) | Filing |
2025-02-14 4:44 pm Purchase | 2023-12-31 | 13G | Lifecore Biomedical, Inc. LFCR | Greenhaven Road Investment Management L.P. | 2,366,956 7.800% | 464,317![]() (+24.40%) | Filing |
2023-06-30 2:46 pm Purchase | 2023-06-21 | 13G | Lifecore Biomedical, Inc. LFCR | Greenhaven Road Investment Management L.P. | 1,902,639 6.300% | 1,902,639![]() (New Position) | Filing |